Literature DB >> 3865348

Treatment of orofacial infections of odontogenic origin.

A Heimdahl, C E Nord.   

Abstract

Acute purulent orofacial infections are often of odontogenic origin. The microorganisms and the anatomical site involved, largely determine the clinical manifestations. The infections are usually self-limiting but serious complications may ensue. Direct invasion of different anatomical spaces may cause mediastinitis, airway obstruction and also intracranial spread. Anaerobic bacteria belonging to the normal oropharyngeal flora (anaerobic cocci, bacteroides and fusobacteria) are usually isolated from orofacial abscesses. Surgical treatment including incision and drainage is essential. The drug of choice for antimicrobial therapy is penicillin. Penicillin resistant anaerobic bacteria may however make penicillin ineffective and antimicrobial agents such as metronidazole or clindamycin are then recommended to be used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865348

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  3 in total

1.  In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.

Authors:  Ingo Sobottka; Georg Cachovan; Enno Stürenburg; M Oliver Ahlers; Rainer Laufs; Ursula Platzer; Dietrich Mack
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Detection of cfxA and cfxA2, the beta-lactamase genes of Prevotella spp., in clinical samples from dentoalveolar infection by real-time PCR.

Authors:  Kaori Iwahara; Tomoari Kuriyama; Satoshi Shimura; David W Williams; Maki Yanagisawa; Kiyomasa Nakagawa; Tadahiro Karasawa
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Evaluation of bacterial spectrum of orofacial infections and their antibiotic susceptibility.

Authors:  Nagendra S Chunduri; Krishnaveni Madasu; Venkateswara R Goteki; Tanveer Karpe; Haranadha Reddy
Journal:  Ann Maxillofac Surg       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.